Title:
MYC PROGRAM AS A MARKER OF RESPONSE TO ENZALUTAMIDE IN PROSTATE
Document Type and Number:
WIPO Patent Application WO/2023/196978
Kind Code:
A3
Abstract:
Provided herein are methods of identifying a subject with prostate cancer (such as a human or veterinary subject) who will respond to enzalutamide therapy. In particular examples, the methods can determine with high accuracy whether a subject is likely to respond to enzalutamide therapy. Also provided are methods for treating a subject who is likely to respond to enzalutamide, for example by administering enzalutamide to the subject.
Inventors:
SCHAEFFER EDWARD (US)
ABDULKADIR SARKI (US)
KOTHARI VISHAL (US)
MITROFANOVA ANTONINA (US)
PANJA SUKANYA (US)
ABDULKADIR SARKI (US)
KOTHARI VISHAL (US)
MITROFANOVA ANTONINA (US)
PANJA SUKANYA (US)
Application Number:
PCT/US2023/065533
Publication Date:
November 16, 2023
Filing Date:
April 07, 2023
Export Citation:
Assignee:
UNIV RUTGERS (US)
SCHAEFFER EDWARD (US)
ABDULKADIR SARKI (US)
KOTHARI VISHAL (US)
SCHAEFFER EDWARD (US)
ABDULKADIR SARKI (US)
KOTHARI VISHAL (US)
International Classes:
A61K31/4174; A61P35/00; C07D233/86; C12Q1/6886; G01N33/574
Domestic Patent References:
| WO2021202428A1 | 2021-10-07 | |||
| WO2020214718A1 | 2020-10-22 |
Attorney, Agent or Firm:
GRAF, Susan W. et al. (US)
Download PDF:
Previous Patent: SYSTEMS AND METHODS FOR SPACE BASED SENSORS
Next Patent: CRYOGENIC COOLING APPARATUS AND RELATED METHODS
Next Patent: CRYOGENIC COOLING APPARATUS AND RELATED METHODS